WASHINGTON—AdvaMed, the Medtech Association, today announced Melissa Torres is the new Executive Vice President of Technology and Regulatory Affairs. Torres succeeds Janet Trunzo, who retired after 30 distinguished, productive years with AdvaMed.
“Our technology and regulatory affairs department is crucial to ensuring patient access to proven, safe, and effective medtech,” said Scott Whitaker, AdvaMed President and CEO. “Whether working with FDA, HHS, or other agencies, this department advocates for transparent, efficient, and established processes to allow innovators to navigate complex regulatory environments. Melissa’s years of experience with the FDA well equip her with the knowledge and skills necessary to lead in this critical role. AdvaMed is also grateful to have a seamless transition between Melissa’s start and Janet’s departure. Janet leaves a tremendous legacy and an outstanding team to continue the tradition of high value to our member companies and the patients they serve.”
Torres joins AdvaMed with over 20 years of leadership in U.S. FDA and international regulatory policy, most recently serving as Associate Director for International Affairs at the FDA’s Center for Devices and Radiological Health. She is widely recognized for her strategic vision and expertise in shaping regulatory frameworks for medical devices, both in the United States and globally. She has led high-impact teams in both premarket and postmarket activities, fostered collaboration among global regulatory authorities, and driven international harmonization efforts to expand patient access to safe and effective medical technologies.
Her technical and executive competencies span regulatory policy development, global strategy, stakeholder engagement, and cross-functional leadership. Torres has managed FDA participation in key international initiatives, including the International Medical Device Regulators Forum (IMDRF) and the Medical Device Single Audit Program (MDSAP). She has also played important roles in developing the Quality Management System Regulation (QMSR) and participated in prior Medical Device User Fee Amendments (MDUFA) negotiations.
Torres holds advanced degrees in engineering management and biomedical engineering from The Catholic University of America and an undergraduate degree in biomedical engineering from Vanderbilt University.
For more on Trunzo’s accomplishments, please see Whitaker’s blog and LinkedIn post.
###
Call to Action Heading…
Call to Action Description…
